Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -228.73% is 22% below its 5-year average of -187.73%, around the middle of its 5-year range (-328.18%–-100.48%).
57.26% below its 12-month average of -145.44%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2027 (2026-06-30): -52.93%.
RETURN ON ASSETS (ROA)
-228.73%
RETURN ON ASSETS (ROA) AVG TTM
-145.44%
RETURN ON ASSETS (ROA) AVG 3Y
-152.25%
RETURN ON ASSETS (ROA) AVG 5Y
-187.73%
RETURN ON ASSETS (ROA) AVG 10Y
-120.49%
RETURN ON ASSETS (ROA) AVG 15Y
-88.36%
RETURN ON ASSETS (ROA) AVG 20Y
-66.27%
CURRENT VS TTM AVG
-57.26%
CURRENT VS 3Y AVG
-50.24%
CURRENT VS 5Y AVG
-21.84%
CURRENT VS 10Y AVG
-89.83%
CURRENT VS 15Y AVG
-158.86%
CURRENT VS 20Y AVG
-245.14%
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
-645.05%
vs the sector median at left
Modular Medical, Inc.
Market Cap
$21.27M
Return on Assets (ROA)
-228.73%
TTM Avg
-145.44%
3Y Avg
-152.25%
5Y Avg
-187.73%
Market Cap
$20.60M
Return on Assets (ROA)
-173.14%
TTM Avg
-158.95%
3Y Avg
-120.45%
5Y Avg
-102.27%
Market Cap
$22.31M
Return on Assets (ROA)
-13.57%
TTM Avg
-12.25%
3Y Avg
-12.55%
5Y Avg
-25.19%
Market Cap
$22.32M
Return on Assets (ROA)
-248.63%
TTM Avg
-139.76%
3Y Avg
-97.50%
5Y Avg
-68.94%
Market Cap
$20.03M
Return on Assets (ROA)
-393.39%
TTM Avg
-225.59%
3Y Avg
-343.91%
5Y Avg
-343.91%
Market Cap
$22.72M
Return on Assets (ROA)
-75.43%
TTM Avg
-148.63%
3Y Avg
-74.35%
5Y Avg
-49.59%
Market Cap
$18.90M
Return on Assets (ROA)
-15.04%
TTM Avg
-19.94%
3Y Avg
-19.35%
5Y Avg
-18.92%
Market Cap
$19.25M
Return on Assets (ROA)
-188.98%
TTM Avg
-90.06%
3Y Avg
-67.42%
5Y Avg
-51.71%
Market Cap
$18.86M
Return on Assets (ROA)
-64.55%
TTM Avg
-0.45%
3Y Avg
-55.72%
5Y Avg
-45.67%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Modular Medical, Inc. (MODD) | $21.27M | -228.73% | -145.44% | -152.25% | -187.73% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.60M | -173.14% | -158.95% | -120.45% | -102.27% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.31M | -13.57% | -12.25% | -12.55% | -25.19% |
| LeonaBio, Inc. (LONA)vs › | $22.32M | -248.63% | -139.76% | -97.50% | -68.94% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.03M | -393.39% | -225.59% | -343.91% | -343.91% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.72M | -75.43% | -148.63% | -74.35% | -49.59% |
| P3 Health Partners Inc. (PIII)vs › | $18.90M | -15.04% | -19.94% | -19.35% | -18.92% |
| NextCure, Inc. (NXTC)vs › | $19.25M | -188.98% | -90.06% | -67.42% | -51.71% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.86M | -64.55% | -0.45% | -55.72% | -45.67% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.60M | -548.74% | -346.44% | -242.08% | -167.09% |
ROA
-228.7%
ROE
-260.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | -190.41% |
| 2025-03-31 | -100.48% |
| 2024-03-31 | -126.53% |
| 2023-03-31 | -191.56% |
| 2022-03-31 | -189.23% |
| 2021-03-31 | -328.18% |
| 2020-03-31 | -137.90% |
| 2019-03-31 | -38.17% |
| 2018-03-31 | -15.21% |
| 2017-06-30 | -7.76% |
| 2016-06-30 | 0.00% |
| 2015-06-30 | -1239.76% |
| 2014-06-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2004-06-30 | -8167.11% |
